☆ 4.7 Editorial Material

The EAST study: redefining the role of rhythm control therapy in atrial fibrillation

EUROPEAN HEART JOURNAL (2015)

期刊

EUROPEAN HEART JOURNAL

卷 36, 期 5, 页码 255-256

出版社

OXFORD UNIV PRESS

DOI: 10.1093/eurheartj/ehu476

关键词

-

类别

Cardiac & Cardiovascular Systems

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

The RACE to the EAST. In pursuit of rhythm control therapy for atrial fibrillation-a dedication to Harry Crijns

Bruno Reissmann, Gunter Breithardt, A. John Camm, Isabelle C. Van Gelder, Andreas Metzner, Paulus Kirchhof

Summary: The RACE trial was a landmark trial that influenced clinical decision-making and highlighted factors related to mortality in rhythm control therapy for atrial fibrillation patients. Overcoming these concerns and gaining important knowledge led to the EAST-AFNET 4 trial, demonstrating the benefits of early rhythm control therapy.

EUROPACE (2021)

添加到收藏夹

Review Medicine, General & Internal

Evolving Role of Catheter Ablation for Atrial Fibrillation: Early and Effective Rhythm Control

Shaojie Chen, Yuehui Yin, Zhiyu Ling, Christian Meyer, Helmut Puererfellner, Martin Martinek, Marcio Galindo Kiuchi, Piotr Futyma, Lin Zhu, Alexandra Schratter, Jiazhi Wang, Willem-Jan Acou, Philipp Sommer, Feifan Ouyang, Shaowen Liu, Julian K. R. Chun, Boris Schmidt

Summary: Catheter ablation is an effective therapeutic option for atrial fibrillation, reducing AF burden and improving clinical outcomes. Early rhythm control is associated with lower risk of adverse cardiovascular outcomes. CA as an initial first line strategy significantly reduces arrhythmia recurrence and rehospitalization in patients with paroxysmal AF. CA lowers the risk of progression from paroxysmal AF to persistent AF. In persistent AF, overall clinical success after ablation is unsatisfactory, but better outcomes are observed in patients with early persistent AF. Adjunctive ablations on top of PVI can further reduce arrhythmia recurrence.

JOURNAL OF CLINICAL MEDICINE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The 2020 ESC atrial fibrillation guidelines for atrial fibrillation catheter ablation, CABANA, and EAST

Elena Arbelo, Nikolaos Dagres

Summary: This article critically reviews the recommendations of the 2020 ESC guidelines for the management of AF in light of two landmark trials, emphasizing the safety of contemporary rhythm control treatment and the importance of personalized treatment strategies.

EUROPACE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Generalizability of the EAST-AFNET 4 Trial: Assessing Outcomes of Early Rhythm-Control Therapy in Patients With Atrial Fibrillation

Jannis Dickow, Paulus Kirchhof, Holly K. Van Houten, Lindsey R. Sangaralingham, Leon H. W. Dinshaw, Paul A. Friedman, Douglas L. Packer, Peter A. Noseworthy, Xiaoxi Yao

Summary: This study aimed to evaluate the generalizability of early rhythm-control therapy (ERC) in routine practice. The results replicate the clinical benefit of ERC seen in EAST-AFNET 4, supporting the adoption of ERC as part of the management of recently diagnosed AF in the United States.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial

Stephan Willems, Katrin Borof, Axel Brandes, Gunter Breithardt, A. John Camm, Harry J. G. M. Crijns, Lars Eckardt, Nele Gessler, Andreas Goette, Laurent M. Haegeli, Hein Heidbuchel, Josef Kautzner, G. Andre Ng, Renate B. Schnabel, Anna Suling, Lukasz Szumowski, Sakis Themistoclakis, Panos Vardas, Isabelle C. van Gelder, Karl Wegscheider, Paulus Kirchhof

Summary: The EAST-AFNET 4 trial showed that early, systematic rhythm control therapy improves clinical outcomes in both symptomatic and asymptomatic atrial fibrillation patients.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Atrial Cardiopathy: Redefining Stroke Risk Beyond Atrial Fibrillation

Jessica Chu Zhang, Aditya Bhat

Summary: Atrial fibrillation (AF) and ischemic stroke are two epidemics with poor clinical outcomes and significant healthcare expenditure. Recent evidence suggests that an intrinsically prothrombotic atrial substrate may lead to thromboembolic events independent of arrhythmia, providing an opportunity for intervention before stroke. Adding parameters of atrial cardiopathy to stroke risk stratification algorithms may be valuable, but requires further evaluation with prospective studies. This review explores the use of atrial cardiopathy measures in stroke risk stratification and management.

AMERICAN JOURNAL OF CARDIOLOGY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial

Lars Eckardt, Susanne Sehner, Anna Suling, Katrin Borof, Guenter Breithardt, Harry Crijns, Andreas Goette, Karl Wegscheider, Antonia Zapf, John Camm, Andreas Metzner, Paulus Kirchhof

Summary: A strategy of systemic, early rhythm control has been found to improve cardiovascular outcomes in atrial fibrillation patients. The presence of sinus rhythm at 12 months is identified as a key mediator of this effect.

EUROPEAN HEART JOURNAL (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Association of genetic risk and outcomes in patients with atrial fibrillation: interactions with early rhythm control in the EAST-AFNET4 trial

Shinwan Kany, Christoph Al-Taie, Carolina Roselli, James P. Pirruccello, Katrin Borof, Carla Reinbold, Anna Suling, Linda Krause, Bruno Reissmann, Renate B. Schnabel, Tanja Zeller, Antonia Zapf, Karl Wegscheider, Larissa Fabritz, Patrick T. Ellinor, Paulus Kirchhof

Summary: The Early Treatment of Atrial Fibrillation for Stroke Prevention Trial has shown that early rhythm control is effective in reducing cardiovascular events in patients with atrial fibrillation (AF). However, the interaction between genetic predisposition to AF and stroke and early rhythm control therapy is still unknown.

CARDIOVASCULAR RESEARCH (2023)

添加到收藏夹

Article Health Care Sciences & Services

Rhythm Control Better Prevents Dementia than Rate Control Strategies in Patients with Atrial Fibrillation-A Nationwide Cohort Study

Jiunn-Cherng Lin, Cheng-Hung Li, Yun-Yu Chen, Chi-Jen Weng, Yu-Shan Chien, Shang-Ju Wu, Chu-Pin Lo, Hui-Chun Tien, Ching-Heng Lin, Jin-Long Huang, Yenn-Jiang Lin, Yu-Cheng Hsieh, Shih-Ann Chen

Summary: Pharmacological rhythm control strategy is associated with a lower risk of dementia in patients with atrial fibrillation, particularly in those receiving aspirin treatment, compared to rate control strategy during long-term follow-up.

JOURNAL OF PERSONALIZED MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Rhythm Control and Cardiovascular or Cerebrovascular Outcomes in Patients with Atrial Fibrillation: A Study of the CODE-AF Registry

Ho-Gi Chung, Junbeom Park, Jin-Kyu Park, Ki-Woon Kang, Jaemin Shim, Jin-Bae Kim, Jun Kim, Eue-Keun Choi, Hyung Wook Park, Young Soo Lee, Boyoung Joung

Summary: This study investigated the relationship between rhythm control and cardiovascular outcomes in a contemporary atrial fibrillation (AF) registry. No difference in the risk of cardiovascular or cerebrovascular outcomes was found between the rhythm control and rate control groups. These findings suggest that early rhythm control should be considered to improve patient outcomes.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Time of onset of atrial fibrillation and atrial fibrillation progression data from the RACE V study

Martijn E. van de Lande, Rajiv S. Rama, Tim Koldenhof, Vicente Artola Arita, Bao-Oanh Nguyen, Colinda van Deutekom, Vanessa Weberndorfer, Harry J. G. M. Crijns, Martin E. W. Hemels, Robert G. Tieleman, Mirko de Melis, Ulrich Schotten, Dominik Linz, Isabelle C. Van Gelder, Michiel Rienstra

Summary: This study aims to assess the association between the time of onset of atrial fibrillation (AF) episodes with the clinical phenotype and AF progression. The results suggest that patients with either predominant nocturnal or daytime onset of AF episodes have less associated comorbidities and less AF progression compared to patients with mixed onset of AF.

EUROPACE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial

Sophie Gottschalk, Shinwan Kany, Hans-Helmut Koenig, Harry J. G. M. Crijns, Panos Vardas, A. John Camm, Karl Wegscheider, Andreas Metzner, Andreas Rillig, Paulus Kirchhof, Judith Dams

Summary: The EAST-AFNET 4 trial found that early rhythm control (ERC) reduces the rate of a composite primary outcome by around 20%. This study investigated the cost-effectiveness of ERC compared to usual care and concluded that, from a German healthcare payer's perspective, health benefits of ERC may come at reasonable costs.

EUROPACE (2023)

添加到收藏夹

Article Clinical Neurology

Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study

Anna Tancin Lambert, Barbara Ratajczak-Tretel, Riadh Al-Ani, Kathrine Arntzen, Grete Kristin Bakkejord, Hanna Marie Otterholt Bekkeseth, Vigdis Bjerkeli, Guttorm Eldoen, Anne Kristine Gulsvik, Bente Halvorsen, Gudrun Anette Hoie, Hege Ihle-Hansen, Hakon Ihle-Hansen, Susanne Ingebrigtsen, Henriette Johansen, Christine Kremer, Siv Bohne Krogseth, Christina Kruuse, Martin Kurz, Ingvild Nakstad, Vojtech Novotny, Halvor Naess, Rehman Qazi, Mehdi Kallaj Rezai, Dag Marius Rorholt, Linn Hofsoy Steffensen, Jesper Somark, Hakon Tobro, Thomas Clement Truelsen, Lejla Wassvik, Karen Lehrmann aegidius, Maiju Pesonen, Mirko de Melis, Dan Atar, Anne Hege Aamodt

Summary: The purpose of this study was to evaluate clinically available biomarkers as predictors of atrial fibrillation (AF). The study found that B-type natriuretic peptide and N-terminal pro-brain natriuretic peptide were significantly associated with AF and could be used to select patients for long-term monitoring.

EUROPEAN JOURNAL OF NEUROLOGY (2023)

添加到收藏夹

Article Geriatrics & Gerontology

Association of rhythm control with incident dementia among patients with atrial fibrillation: a nationwide population-based cohort study

Daehoon Kim, Pil-Sung Yang, Seng Chan You, Jung-Hoon Sung, Eunsun Jang, Hee Tae Yu, Tae-Hoon Kim, Hui-Nam Pak, Moon-Hyoung Lee, Gregory Y. H. Lip, Boyoung Joung

Summary: This study found that among anticoagulated patients with AF, rhythm control was associated with a lower risk of dementia compared with rate control. The association was more pronounced in younger patients and those with lower stroke risk factors. Initiating rhythm control in AF patients with fewer stroke risk factors might help prevent subsequent dementia.

AGE AND AGEING (2022)

添加到收藏夹

Article Medicine, General & Internal

Prognostic significance of present atrial fibrillation on a single office electrocardiogram in patients with atrial fibrillation

P. Krisai, P. Hammerle, S. Blum, P. Meyre, S. Aeschbacher, P. Melchiorre-Mayer, O. Baretella, N. Rodondi, D. Conen, S. Osswald, M. Kuhne, C. S. Zuern

Summary: The presence of atrial fibrillation (AF) on a single surface ECG is significantly associated with increased risk of mortality and hospitalizations for congestive heart failure in AF patients, suggesting that these patients are a high-risk group that may benefit from intensified treatment.

JOURNAL OF INTERNAL MEDICINE (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

3 Tesla magnetic resonance imaging in patients with cardiac implantable electronic devices: a single centre experience

Nina Fluschnik, Enver Tahir, Jennifer Erley, Kai Muellerleile, Andreas Metzner, Jan-Per Wenzel, Helena Guerreiro, Gerhard Adam, Stefan Blankenberg, Paulus Kirchhof, Tobias Toennis, Julius Nikorowitsch

Summary: Pending verification in independent series, clinically indicated MRI scans at 3T field strength should not be withheld from patients with cardiac pacemakers or defibrillators, as our data suggest that it is safe and does not result in adverse events in most cases.

EUROPACE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

PITX2 Knockout Induces Key Findings of Electrical Remodeling as Seen in Persistent Atrial Fibrillation

Carl Schulz, Marc D. Lemoine, Giulia Mearini, Jussi Koivumaeki, Jascha Sani, Edzard Schwedhelm, Paulus Kirchhof, Amer Ghalawinji, Monika Stoll, Arne Hansen, Thomas Eschenhagen, Torsten Christ

Summary: This study found that deletion of the PITX2 gene in human induced pluripotent stem cell-derived atrial cardiomyocytes results in some abnormalities similar to electrical remodeling in atrial fibrillation. These findings suggest that the PITX2 gene plays an important role in the occurrence of atrial fibrillation.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Outcomes of Early Rhythm Control Therapy in Patients With Atrial Fibrillation and a High Comorbidity Burden in Large Real-World Cohorts

Jannis Dickow, Shinwan Kany, Victor Roth Cardoso, Patrick T. Ellinor, Georgios V. Gkoutos, Holly K. Van Houten, Paulus Kirchhof, Andreas Metzner, Peter A. Noseworthy, Xiaoxi Yao, Andreas Rillig

Summary: A recent study suggests that early rhythm control is more beneficial for patients with atrial fibrillation and a high comorbidity burden. This study analyzed a large database and found that early rhythm control can reduce the risk of death, stroke, heart failure, or myocardial infarction in patients with a high comorbidity burden.

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Avoiding unnecessary ventricular pacing is associated with reduced incidence of heart failure hospitalizations and persistent atrial fibrillation in pacemaker patients

Martin Arnold, Mark Richards, Antonio D'Onofrio, Brett Faulknier, Michele Gulizia, Ranjan Thakur, Yasushi Sakata, Wenjiao Lin, Annalisa Pollastrelli, Andrea Grammatico, Angelo Auricchio, Giuseppe Boriani

Summary: In bradycardia patients treated with dual-chamber pacing, pacing with AV delay management (AVH) reduces unnecessary ventricular pacing percentage (VPP) and is associated with better clinical outcomes.

EUROPACE (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Cost-effectiveness of early rhythm control vs. usual care in atrial fibrillation care: an analysis based on data from the EAST-AFNET 4 trial

Sophie Gottschalk, Shinwan Kany, Hans-Helmut Koenig, Harry J. G. M. Crijns, Panos Vardas, A. John Camm, Karl Wegscheider, Andreas Metzner, Andreas Rillig, Paulus Kirchhof, Judith Dams

Summary: The EAST-AFNET 4 trial found that early rhythm control (ERC) reduces the rate of a composite primary outcome by around 20%. This study investigated the cost-effectiveness of ERC compared to usual care and concluded that, from a German healthcare payer's perspective, health benefits of ERC may come at reasonable costs.

EUROPACE (2023)

添加到收藏夹

Editorial Material Cardiac & Cardiovascular Systems

Good rhythm control without haste: atrial fibrillation ablation remains effective after a year of waiting

Andreas Metzner, Paulus Kirchhof

EUROPEAN HEART JOURNAL (2023)

添加到收藏夹

Review Hematology

Protocol for a Systematic Review and Individual Participant Data Meta-Analysis of Randomized Trials of Screening for Atrial Fibrillation to Prevent Stroke

William McIntyre

Summary: Atrial fibrillation is a common cause of stroke. Timely diagnosis and treatment with oral anticoagulation can prevent many AF-related strokes. However, the impact of population-based ECG screening on stroke is uncertain as current RCTs lack sufficient power.

THROMBOSIS AND HAEMOSTASIS (2023)

添加到收藏夹

Article Medicine, Research & Experimental

Lenient rate control versus strict rate control for atrial fibrillation: a statistical analysis plan for the Danish Atrial Fibrillation (DanAF) randomized clinical trial

Isak Mazanti Cold, Joshua Buron Feinberg, Axel Brandes, Ulla Davidsen, Ulrik Dixen, Helena Dominguez, Uffe Jakob Ortved Gang, Christian Gluud, Rakin Hadad, Kit Engedal Kristensen, Doan Tuyet van Le, Emil Eik Nielsen, Michael Hecht Olsen, Ole Dyg Pedersen, Ilan Esra Raymond, Ahmad Sajadieh, Anne Merete Boas Soja, Janus Christian Jakobsen

Summary: This study aims to compare strict rate control with lenient rate control in patients with atrial fibrillation. The primary outcome is the physical component score of the SF-36 questionnaire. All secondary outcomes will be hypothesis-generating. The analysis will be based on the intention-to-treat principle and use linear regression for adjustment.

TRIALS (2023)

添加到收藏夹

Article Medicine, General & Internal

Atorvastatin and the influence on postoperative atrial fibrillation after surgical aortic valve replacement (STARC) in adults at Odense University Hospital, Denmark: study protocol for a randomised controlled trial

Lytfi Krasniqi, Axel Brandes, Poul Erik Mortensen, Jordi Sanchez Dahl, Oke Gerke, Mulham Ali, Lars Peter Schodt Riber

Summary: This study aims to investigate whether prophylactic administration of atorvastatin reduces postoperative atrial fibrillation (POAF) in patients undergoing surgical aortic valve replacement (SAVR). The study is a randomized, double-blind, placebo-controlled trial involving 266 patients without a history of AF or statin use. The primary endpoint is the occurrence of POAF, documented by rhythm strip or 12-lead ECG.

BMJ OPEN (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Prevalence and Prognostic Significance of Bradyarrhythmias in Patients Screened for Atrial Fibrillation vs Usual Care Post Hoc Analysis of the LOOP Randomized Clinical Trial

Soren Zoega Diederichsen, Lucas Yixi Xing, Diana My Frodi, Emilie Katrine Kongebro, Ketil Jorgen Haugan, Claus Graff, Soren Hojberg, Derk Krieger, Axel Brandes, Lars Kober, Jesper Hastrup Svendsen

Summary: There is a growing interest in heart rhythm monitoring and the detection of subclinical atrial fibrillation (AF) which may identify cases of bradyarrhythmias. This study aimed to assess the prevalence and prognostic significance of bradyarrhythmias in individuals screened for AF using an implantable loop recorder (ILR). The results showed that more than 1 in 5 individuals over the age of 70 with cardiovascular risk factors can be diagnosed with bradyarrhythmias when long-term continuous monitoring for AF is applied. ILR screening led to a significant increase in the diagnosis of bradyarrhythmias and pacemaker implantations compared with usual care, but there was no change in the risk of syncope or sudden death.

JAMA CARDIOLOGY (2023)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Acute lesion extension following pulmonary vein isolation with two novel single shot devices: Pulsed field ablation versus multielectrode radiofrequency balloon

Ilaria My, Marc D. Lemoine, Mahi Butt, Celine Mencke, Fabian W. Loeck, Julius Obergassel, Laura Rottner, Jan-Per Wenzel, Ruben Schleberger, Julia Moser, Fabian Moser, Paulus Kirchhof, Bruno Reissmann, Feifan Ouyang, Andreas Rillig, Andreas Metzner

Summary: This study compared the acute lesion extent after pulmonary vein isolation (PVI) induced by pulsed-field ablation (PFA) and multielectrode radiofrequency balloon (RFB). The results showed that PFA resulted in larger ablation areas and higher release of cardiac injury biomarkers compared to RFB.

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY (2023)

添加到收藏夹

Article Physiology

Localized cardiomyocyte lipid accumulation is associated with slowed epicardial conduction in rats

Simon P. Wells, Antonia J. A. Raaijmakers, Claire L. Curl, Christopher O'Shea, Sarah Hayes, Kimberley M. Mellor, Jonathan M. Kalman, Paulus Kirchhof, Davor Pavlovic, Lea M. D. Delbridge, James R. Bell

Summary: This study demonstrates that the transmural conduction gradient in rat ventricular slices is abolished when there is increased pericardial adiposity, with slowed epicardial conduction correlating with an increase in cardiomyocyte lipid content. This gradient is important in reducing vulnerability to arrhythmias, and its absence due to conduction slowing and cardiomyocyte lipid accumulation suggests a novel mechanism by which pericardial adiposity may exacerbate ventricular arrhythmias.

JOURNAL OF GENERAL PHYSIOLOGY (2023)

添加到收藏夹

Article Medicine, Research & Experimental

An arrhythmogenic metabolite in atrial fibrillation

Julia Krause, Alexander Nickel, Alexandra Madsen, Hamish M. Aitken-Buck, A. M. Stella Stoter, Jessica Schrapers, Francisco Ojeda, Kira Geiger, Melanie Kern, Michael Kohlhaas, Edoardo Bertero, Patrick Hofmockel, Florian Huebner, Ines Assum, Matthias Heinig, Christian Mueller, Arne Hansen, Tobias Krause, Deung-Dae Park, Steffen Just, Dylan Aissi, Daniela Boernigen, Diana Lindner, Nele Friedrich, Khaled Alhussini, Constanze Bening, Renate B. Schnabel, Mahir Karakas, Licia Iacoviello, Veikko Salomaa, Allan Linneberg, Hugh Tunstall-Pedoe, Kari Kuulasmaa, Paulus Kirchhof, Stefan Blankenberg, Torsten Christ, Thomas Eschenhagen, Regis R. Lamberts, Christoph Maack, Justus Stenzig, Tanja Zeller

Summary: Long-chain acyl-carnitines, specifically C18:1AC, have been found to be potential arrhythmogenic metabolites. This metabolite has biphasic effects on cardiac electrophysiology and metabolism, and has the potential to serve as a circulating biomarker for predicting risk of atrial fibrillation.

JOURNAL OF TRANSLATIONAL MEDICINE (2023)

添加到收藏夹

Article Clinical Neurology

Independent external validation of a stroke recurrence score in patients with embolic stroke of undetermined source

Thies Ingwersen, Manuel C. Olma, Eckhard Schlemm, Carola Mayer, Bastian Cheng, Serdar Tuetuencue, Paulus Kirchhof, Roland Veltkamp, Joachim Roether, Ulrich Laufs, Darius G. Nabavi, George Ntaios, Matthias Endres, Karl Georg Haeusler, Goetz Thomalla

Summary: This study externally validated the ESUS recurrence score and supported a threshold of >= 7 for identifying ESUS patients at high-risk of stroke recurrence. However, further adjustments may be needed to improve the model's performance in independent cohorts. The use of risk scores may be helpful in guiding extended diagnostics and further trials on secondary prevention in patients with ESUS.

NEUROLOGICAL RESEARCH AND PRACTICE (2023)

添加到收藏夹

Article Multidisciplinary Sciences

An angiopoietin 2, FGF23, and BMP10 biomarker signature differentiates atrial fibrillation from other concomitant cardiovascular conditions

Winnie Chua, Victor R. Cardoso, Eduard Guasch, Moritz F. Sinner, Christoph Al-Taie, Paul Brady, Barbara Casadei, Harry J. G. M. Crijns, Elton A. M. P. Dudink, Stephane N. Hatem, Stefan Kaeaeb, Peter Kastner, Lluis Mont, Frantisek Nehaj, Yanish Purmah, Jasmeet S. Reyat, Ulrich Schotten, Laura C. Sommerfeld, Stef Zeemering, Andre Ziegler, Georgios V. Gkoutos, Paulus Kirchhof, Larissa Fabritz

Summary: Early detection of atrial fibrillation through the measurement of circulating biomarkers can reduce the risk of stroke, cardiovascular death, and heart failure.

SCIENTIFIC REPORTS (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.